Heidelberg Pharma AG
XHAM:HPHA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Heidelberg Pharma AG
XHAM:HPHA
|
DE |
|
Wolfspeed Inc
NYSE:WOLF
|
US |
|
C
|
Cleveland-Cliffs Inc
F:CVA
|
US |
|
W
|
Wacker Neuson SE
XBER:WAC
|
DE |
|
J
|
JAFCO Group Co Ltd
F:JAF
|
JP |
|
M
|
Memscap SA
F:MSBA
|
FR |
|
Kraft Heinz Co
NASDAQ:KHC
|
US |
|
Temenos AG
F:TE8N
|
CH |
|
U
|
United Microelectronics Corp
F:UMCB
|
TW |
|
Valeo Pharma Inc
F:VP2
|
CA |
|
O
|
OC Oerlikon Corporation AG Pfaeffikon
XMUN:OBH
|
CH |
|
A
|
Alpha Pro Tech Ltd
AMEX:APT
|
CA |
|
Straumann Holding AG
F:QS5
|
CH |
Wall St Price Targets
HPHA Price Targets Summary
Heidelberg Pharma AG
According to Wall Street analysts, the average 1-year price target for HPHA is 5.5 EUR with a low forecast of 5.45 EUR and a high forecast of 5.67 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HPHA's stock price target?
Price Target
5.5
EUR
According to Wall Street analysts, the average 1-year price target for HPHA is 5.5 EUR with a low forecast of 5.45 EUR and a high forecast of 5.67 EUR.
What is the Revenue forecast for Heidelberg Pharma AG?
Projected CAGR
202%
Over the last 9 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 2 years is 202%.
What is the Gross Profit forecast for Heidelberg Pharma AG?
Projected CAGR
26%
Over the last 9 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 5 years is 26%.
